机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.四川大学华西医院[2]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address: hanping@scu.edu.cn.四川大学华西医院[3]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address: weiwuranwch@126.com.四川大学华西医院
第一作者机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
通讯作者:
推荐引用方式(GB/T 7714):
Shi Xu,Feng Dechao,Han Ping,et al.Crystallin zeta serves as a prognostic biomarker for patients with kidney renal clear cell carcinoma[J].Asian journal of surgery.2023,doi:10.1016/j.asjsur.2023.02.001.
APA:
Shi Xu,Feng Dechao,Han Ping&Wei Wuran.(2023).Crystallin zeta serves as a prognostic biomarker for patients with kidney renal clear cell carcinoma.Asian journal of surgery,,
MLA:
Shi Xu,et al."Crystallin zeta serves as a prognostic biomarker for patients with kidney renal clear cell carcinoma".Asian journal of surgery .(2023)